Clover Health
- Market cap
- 2.42B
- P/E (TTM)i
- -91.20
- P/Bi
- 6.44
- EPSi
- -0.17
- Div yieldi
- 0.00%
- 52W posi
- 74%
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions increased by 5 in the most recent period (2026/Q3).
- Total institutional ownership rose 0.3 percentage points.
Institutional ownership
- Held by institutions
- 28.23% +0.30pp
- Institutions
- 260 +5
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Top holders as of 2026-03-31
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 4 buys · 44 sells
| Name | Role | Stake |
|---|---|---|
| Vivek Garipalli | Co-Founder & Executive Chairperson | 17.62% |
| Andrew Toy | Chief Executive Officer | 1.22% |
| Jamie Reynoso | Divisional Chief Executive Officer of Medicare Advantage | 0.53% |
| Conrad Wai | Chief Technology Officer | 0.42% |
| Brady Priest | Chief Executive Officer of Home Care | 0.38% |
| Karen Soares | Deputy General Counsel & Corporate Secretary | 0.30% |
| Peter Kuipers | Chief Financial Officer | 0.30% |
| Clay Thornton | Chief Financial Officer of Medicare Advantage Division | 0.24% |
| Chelsea Clinton | Independent Director | 0.10% |
| Lee Shapiro | Independent Director | 0.10% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-04 | Jamie Reynoso | Divisional Chief Executive Officer of Medicare Advantage | Open Market Disposition | -8,750 | $4.42 |
| 2026-09-30 | Andrew Toy | Chief Executive Officer | Open Market Disposition | -318,806 | $4.19 |
| 2026-09-29 | Robert Torricelli | Director | Other Acquisition | +12,481 | -- |
| 2026-09-29 | Brian Miller | Director | Other Acquisition | +12,481 | -- |
| 2026-09-23 | Brady Priest | Chief Executive Officer of Home Care | Intent to Sell (Form 144) | -141,418 | $4.46 |
| 2026-09-21 | Robert Torricelli | Director | Initial Statement of Beneficial | 0 | -- |
| 2026-09-16 | Jamie Reynoso | Divisional Chief Executive Officer of Medicare Advantage | Automatic Disposition | -1,921 | $4.56 |
| 2026-09-15 | Joseph Oldakowski | VP of Finance & Controller | Open Market Disposition | -3,170 | $4.64 |
| 2026-09-14 | Karen Soares | Deputy General Counsel & Corporate Secretary | Open Market Disposition | -6,846 | $4.78 |
| 2026-09-14 | Brady Priest | Chief Executive Officer of Home Care | Intent to Sell (Form 144) | -215,291 | $4.64 |
| 2026-09-14 | Jamie Reynoso | Divisional Chief Executive Officer of Medicare Advantage | Open Market Disposition | -9,273 | $4.78 |
| 2026-09-14 | Conrad Wai | Chief Technology Officer | Automatic Disposition | -300,000 | $4.72 |
| 2026-09-13 | Joseph Oldakowski | VP of Finance & Controller | Open Market Disposition | -20,000 | $5.16 |
| 2026-08-30 | Brady Priest | Chief Executive Officer of Home Care | Intent to Sell (Form 144) | -73,516 | $4.15 |
| 2026-08-16 | Clay Thornton | Chief Financial Officer of Medicare Advantage Division | Open Market Disposition | -17,775 | $4.39 |
| 2026-08-13 | Brady Priest | Chief Executive Officer of Home Care | Intent to Sell (Form 144) | -474,801 | $4.57 |
| 2026-08-11 | Karen Soares | Deputy General Counsel & Corporate Secretary | Other Acquisition | +108,695 | -- |
| 2026-08-11 | Clay Thornton | Chief Financial Officer of Medicare Advantage Division | Other Acquisition | +54,347 | -- |
| 2026-08-09 | Andrew Toy | Chief Executive Officer | Open Market Disposition | -87,798 | $4.65 |
| 2026-08-06 | Brady Priest | Chief Executive Officer of Home Care | Intent to Sell (Form 144) | -441,601 | $4.85 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 05:51:28 · For reference only, not investment advice and not tailored to your situation.